Frederick Hayden to Angiotensin Receptor Antagonists
This is a "connection" page, showing publications Frederick Hayden has written about Angiotensin Receptor Antagonists.
Connection Strength
0.065
-
Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis. Front Med. 2020 Oct; 14(5):601-612.
Score: 0.065